Newbury Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Newbury Pharmaceuticals has a total shareholder equity of SEK40.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK84.1M and SEK43.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr6.41m |
Equity | kr40.78m |
Total liabilities | kr43.35m |
Total assets | kr84.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NEWBRY's short term assets (SEK35.6M) exceed its short term liabilities (SEK31.4M).
Long Term Liabilities: NEWBRY's short term assets (SEK35.6M) exceed its long term liabilities (SEK11.9M).
Debt to Equity History and Analysis
Debt Level: NEWBRY is debt free.
Reducing Debt: NEWBRY has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NEWBRY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NEWBRY has less than a year of cash runway if free cash flow continues to grow at historical rates of 12.3% each year.